USP22 and non-small cell lung carcinoma: In this study, we also found that USP22 is upregulated in lung adenocarcinoma; and upregulation of USP22 protein was more frequently found in advanced stage and was associated with the recurrence of NSCLC, indicating USP22 plays oncogenic roles in NSCLC.